Acurx pharmaceuticals to present at the emerging growth conference on january 25, 2023

Acurx invites individual and institutional investors, financial advisors and analysts to attend its real-time, interactive question and answer session at the emerging growth conference staten island, n.y. , jan. 16, 2023  /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, is pleased to announce that it has been invited to present at the emerging growth conference on january 25, 2023.
ACXP Ratings Summary
ACXP Quant Ranking